Literature DB >> 26063704

β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.

Keyvan Karimi Galougahi1, Chia-Chi Liu2, Alvaro Garcia2, Natasha A Fry2, Elisha J Hamilton2, Gemma A Figtree1, Helge H Rasmussen3.   

Abstract

Dysregulated nitric oxide (NO)- and superoxide (O2 (·-))-dependent signaling contributes to the pathobiology of diabetes-induced cardiovascular complications. We examined if stimulation of β3-adrenergic receptors (β3-ARs), coupled to endothelial NO synthase (eNOS) activation, relieves oxidative inhibition of eNOS and the Na(+)-K(+) pump induced by hyperglycemia. Hyperglycemia was established in male New Zealand White rabbits by infusion of the insulin receptor antagonist S961 for 7 days. Hyperglycemia increased tissue and blood indexes of oxidative stress. It induced glutathionylation of the Na(+)-K(+) pump β1-subunit in cardiac myocytes, an oxidative modification causing pump inhibition, and reduced the electrogenic pump current in voltage-clamped myocytes. Hyperglycemia also increased glutathionylation of eNOS, which causes its uncoupling, and increased coimmunoprecipitation of cytosolic p47(phox) and membranous p22(phox) NADPH oxidase subunits, consistent with NADPH oxidase activation. Blocking translocation of p47(phox) to p22(phox) with the gp91ds-tat peptide in cardiac myocytes ex vivo abolished the hyperglycemia-induced increase in glutathionylation of the Na(+)-K(+) pump β1-subunit and decrease in pump current. In vivo treatment with the β3-AR agonist CL316243 for 3 days eliminated the increase in indexes of oxidative stress, decreased coimmunoprecipitation of p22(phox) with p47(phox), abolished the hyperglycemia-induced increase in glutathionylation of eNOS and the Na(+)-K(+) pump β1-subunit, and abolished the decrease in pump current. CL316243 also increased coimmunoprecipitation of glutaredoxin-1 with the Na(+)-K(+) pump β1-subunit, which may reflect facilitation of deglutathionylation. In vivo β3-AR activation relieves oxidative inhibition of key cardiac myocyte proteins in hyperglycemia and may be effective in targeting the deleterious cardiac effects of diabetes.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  Na+-K+ pump; diabetes; endothelial nitric oxide synthase; glutathionylation; hyperglycemia; β3-adrenergic receptors

Mesh:

Substances:

Year:  2015        PMID: 26063704      PMCID: PMC4556897          DOI: 10.1152/ajpcell.00071.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  49 in total

1.  Correlates of markers of oxidative status in the general population.

Authors:  M Trevisan; R Browne; M Ram; P Muti; J Freudenheim; A M Carosella; D Armstrong
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

2.  Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level.

Authors:  E Bakopanos; J E Silva
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

3.  Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.

Authors:  Tomasz J Guzik; Shafi Mussa; Daniela Gastaldi; Jerzy Sadowski; Chandi Ratnatunga; Ravi Pillai; Keith M Channon
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

4.  Alloxan-induced mitochondrial permeability transition triggered by calcium, thiol oxidation, and matrix ATP.

Authors:  K Sakurai; M Katoh; Y Fujimoto
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

5.  Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle.

Authors:  Guichun Han; Handong Ma; Rajesh Chintala; David J R Fulton; Scott A Barman; Richard E White
Journal:  J Pharmacol Exp Ther       Date:  2009-03-17       Impact factor: 4.030

6.  Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.

Authors:  An L Moens; Jordan S Leyton-Mange; Xiaolin Niu; Ronghua Yang; Oscar Cingolani; Elisabeth K Arkenbout; Hunter C Champion; Djahida Bedja; Kathleen L Gabrielson; Juan Chen; Yong Xia; Ashley B Hale; Keith M Channon; Marc K Halushka; Norman Barker; Floris L Wuyts; Pawel M Kaminski; Michael S Wolin; David A Kass; Lili A Barouch
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

Review 7.  The use of beta3-adrenergic receptor agonists in the treatment of heart failure.

Authors:  Helge H Rasmussen; Gemma A Figtree; Henry Krum; Henning Bundgaard
Journal:  Curr Opin Investig Drugs       Date:  2009-09

8.  Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation.

Authors:  Gemma A Figtree; Chia-Chi Liu; Stephanie Bibert; Elisha J Hamilton; Alvaro Garcia; Caroline N White; Karin K M Chia; Flemming Cornelius; Kaethi Geering; Helge H Rasmussen
Journal:  Circ Res       Date:  2009-06-18       Impact factor: 17.367

9.  Angiotensin II inhibits the Na+-K+ pump via PKC-dependent activation of NADPH oxidase.

Authors:  Caroline N White; Gemma A Figtree; Chia-Chi Liu; Alvaro Garcia; Elisha J Hamilton; Karin K M Chia; Helge H Rasmussen
Journal:  Am J Physiol Cell Physiol       Date:  2009-02-04       Impact factor: 4.249

10.  Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes.

Authors:  Susan Sam; Steven Haffner; Michael H Davidson; Ralph B D'Agostino; Steven Feinstein; George Kondos; Alfonso Perez; Theodore Mazzone
Journal:  Diabetes Care       Date:  2009-02-19       Impact factor: 19.112

View more
  7 in total

Review 1.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

2.  β3-Adrenoceptor, glutathionylation, and diabetic cardiomyopathy. Focus on "β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade".

Authors:  Stephen M Black
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-15       Impact factor: 4.249

3.  Role of the β3-adrenergic receptor subtype in catecholamine-induced myocardial remodeling.

Authors:  Gizem Kayki Mutlu; Ebru Arioglu Inan; Irem Karaomerlioglu; V Melih Altan; Nilgun Yersal; Petek Korkusuz; Marcella Rocchetti; Antonio Zaza
Journal:  Mol Cell Biochem       Date:  2018-01-23       Impact factor: 3.396

4.  β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Carmine Gentile; Natasha A Fry; Elisha J Hamilton; Clare L Hawkins; Gemma A Figtree
Journal:  J Am Heart Assoc       Date:  2016-02-19       Impact factor: 5.501

5.  Visceral Fat Dysfunctions in the Rat Social Isolation Model of Psychosis.

Authors:  Stefania Schiavone; Giulia M Camerino; Emanuela Mhillaj; Margherita Zotti; Marilena Colaianna; Angelo De Giorgi; Antonello Trotta; Francesco P Cantatore; Elena Conte; Maria Bove; Paolo Tucci; Maria G Morgese; Luigia Trabace
Journal:  Front Pharmacol       Date:  2017-11-08       Impact factor: 5.810

Review 6.  The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues.

Authors:  Lauriane Y M Michel; Charlotte Farah; Jean-Luc Balligand
Journal:  Cells       Date:  2020-12-02       Impact factor: 6.600

Review 7.  Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.

Authors:  Raffaele Altara; Mauro Giordano; Einar S Nordén; Alessandro Cataliotti; Mazen Kurdi; Saeed N Bajestani; George W Booz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-17       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.